State of the art treatments for cannabis dependence
I Danovitch, DA Gorelick - Psychiatric Clinics, 2012 - psych.theclinics.com
Worldwide, cannabis is the most commonly used illicit substance. 1 In the United States,
42% of persons over age 12 have used cannabis at least once in their lifetime, 11.5% have …
42% of persons over age 12 have used cannabis at least once in their lifetime, 11.5% have …
Pharmacological treatment of cannabis dependence
AM Weinstein, DA Gorelick - Current pharmaceutical design, 2011 - ingentaconnect.com
Cannabis is the most frequently used illegal psychoactive substance in the world. There is a
significant increase in the number of treatment admissions for cannabis use disorders in the …
significant increase in the number of treatment admissions for cannabis use disorders in the …
[图书][B] Marihuana y salud
JR Fuente - 2015 - books.google.com
Fruto de los trabajos de un grupo de investigadores e instituciones coordinados por Juan
Ramón de la Fuente, a través del Seminario de Estudios sobre la Globalidad de la UNAM …
Ramón de la Fuente, a través del Seminario de Estudios sobre la Globalidad de la UNAM …
Catechol-O-Methyltransferase Effects on Smoking: A Review and Proof of Concept of Sex-Sensitive Effects
EE DeVito, M Sofuoglu - Current behavioral neuroscience reports, 2022 - Springer
Abstract Purpose of Review This article reviews recent research on how catechol-O-
methyltransferase (COMT) may impact cigarette smoking behavior, and how effects may be …
methyltransferase (COMT) may impact cigarette smoking behavior, and how effects may be …
COMT Val158Met modulates subjective responses to intravenous nicotine and cognitive performance in abstinent smokers
AI Herman, PI Jatlow, J Gelernter, JB Listman… - The …, 2013 - nature.com
The catechol-O-methyltransferase (COMT) Val158Met polymorphism may be a risk factor for
nicotine addiction. This study examined the influence of the COMT Val158Met polymorphism …
nicotine addiction. This study examined the influence of the COMT Val158Met polymorphism …
Pharmacotherapies for adolescent substance use disorders
DR Simkin, S Grenoble - Child and Adolescent Psychiatric …, 2010 - childpsych.theclinics.com
Reports on pharmacotherapy of substance use disorders (SUD) have been published
mostly in adults. This article focuses on adolescents less than 19 years of age. However, it is …
mostly in adults. This article focuses on adolescents less than 19 years of age. However, it is …
Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute …
Rationale The catechol-O-methyl transferase (COMT) enzyme has been implicated in
determining dopaminergic tone and the effects of delta-9-tetrahydrocannabinol (THC) in the …
determining dopaminergic tone and the effects of delta-9-tetrahydrocannabinol (THC) in the …
The treatment of cannabis use disorder
I Danovitch, DA Gorelick - The Assessment and Treatment of Addiction, 2019 - Elsevier
Cannabis is the most commonly used illicit substance worldwide. Approximately 8%–12% of
persons who use cannabis will develop cannabis use disorder (CUD) at some point in their …
persons who use cannabis will develop cannabis use disorder (CUD) at some point in their …
The Impact of Temperament and Character on Treatment Compliance of Opioid Agonists
Background: Opioid agonist treatment, as the most effective treatment for opioid
dependency, requires patient adherence for its effectiveness in the long run. Previous …
dependency, requires patient adherence for its effectiveness in the long run. Previous …
The treatment of cannabis use disorder among individuals with a psychotic disorder
P Bosanac, A Lusicic, DJ Castle - The complex connection between …, 2018 - Elsevier
Cannabis use disorder is one of the most frequent substance use disorders among
individuals with psychotic disorders. Over the past decade there has been emerging data on …
individuals with psychotic disorders. Over the past decade there has been emerging data on …